Prevalence of fluconazole-resistant strains of Candida albicans in otherwise healthy outpatients

Journal of Oral Pathology and Medicine

Volumn 31, Issue 2, 2002, Pages 99-105

  Haberland Carrodeguas, Christel ^a   Allen, Carl M ^a   Beck, F Michael ^a   Buesching, William J ^b   Koletar, Susan L ^c   Sundstrom, Paula ^d  

^a DIVISION OF REPRODUCTIVE BIOLOGY   (United States)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c RESEARCH AND DEVELOPMENT   (Australia)

^d TEMPLE UNIVERSITY   (United States)

Author keywords

Antifungal treatment; Candida albicans; Fluconazole; In vitro susceptibility testing; Oral candidiasis; Yeast strain differentiation

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; FUNGAL DNA;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA ALBICANS; CHI SQUARE DISTRIBUTION; DRUG EFFECT; FEMALE; HETEROZYGOTE; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; SOUTHERN BLOTTING; THRUSH; TREATMENT OUTCOME;

ADULT; ANTIFUNGAL AGENTS; BLOTTING, SOUTHERN; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CARRIER STATE; CHI-SQUARE DISTRIBUTION; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MYCOLOGICAL TYPING TECHNIQUES; TREATMENT OUTCOME;

EID: 0035999758     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2002.310207.x     Document Type: Article

References (39)

1. Diagnosing and managing oral candidiasis
2. Oral candidiasis
3. Etiology, pathogenesis, therapy and prophylaxis of oral yeast infections
4. Update on antifungal resistance
5. Diagnosis and treatment of oral candidiasis
6. Resistant candidiasis
7. Resistance of candida species to fluconazole
8. Candida albicans: A review of its history, taxonomy, epidemiology, virulence attributes, and methods of strain differentiation
9. Genetic dissimilarities of candida albicans strains from vaginitis patients and their partners
10. Genetic dissimilarities of commensal strains of candida spp. carried in different anatomical locations of the same healthy women
11. Molecular probe for typing strains of candida albicans
12. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of candida albicans from patients with AIDS and oral candidiasis
13. Correlation of in vitro fluconazole resistance of candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type I
14. Development of resistance in candida isolates from patients receiving prolonged antifungal therapy
15. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to candida albicans
16. Refractory mucosal candidiasis in advanced human immunodeficiency virus infection
17. Isoation of fluconazole-resistant candida albicans from human immunodeficiency virus-negative patients never treated with azoles
18. In vitro antifungal resistance of oral candida albicans strains in non-aids patients
19. Response to fluconazole and itraconazole of candida spp. in denture stomatitis
20. Drug interactions with fluconazole
21. Synthesis of nucleic acids and proteins in the dimorphic forms of candida albicans
22. Biotypes of candida albicans using the API 20C system
23. Application of DNA typing methods to epidemiology and taxonomy of candida species
24. Sequence analysis and expression of the two genes for elongation factor 1alpha from the dimorphic yeast candida albicans
25. Computer-assisted methods for assessing strain relatedness in candida albicans by fingerprinting with the moderately repetitive sequence Ca3
26. Antifungal susceptibility testing: Technical advances and potential clinical applications
27. Development of interpretative breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections
28. Mixed oropharyngeal candidiasis due to candida albicans and non-albicans candida strains in HIV-infected patients
29. Non-albicans candidosis in HIV-positive patients
30. Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment, and emergence of fluconazole resistance
31. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in candida albicans
32. The identification and tracking of candida albicans isolates from oral lesions in HIV-seropositive individuals
33. Correlation between antifungal susceptibility testing of candida isolates from patients with HIV infection and clinical results after treatment with fluconazole
34. Fluconazole response patterns in HIV-infected patients with oropharyngeal candidiasis
35. Fluconazole in the treatment of oropharyngeal candida infection in HIV-positive patients
36. Fluconazole therapy of oral candidiasis in HIV-infected patients: Results of a multicentre study
37. Fluconazole-resistant candida albicans